Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co., Ltd. is a pharmaceutical manufacturing company listed on the ChiNext board of the Shenzhen Stock Exchange since 2017. The company specializes in the research, development, production, and sale of molecular diagnostic products aimed at precision oncology. Amoy Diagnostics is committed to technological innovation and regulatory compliance, ensuring high-quality testing reagents and services for cancer patients. The company has established a strong R&D team and has developed a comprehensive product line with advanced technologies. The main business lines of Amoy Diagnostics include a wide portfolio of detection assays for various cancer types, many of which are first-in-class in China and have received NMPA approval. The company operates dual R&D centers in Xiamen and Shanghai and has built strategic partnerships with leading pharmaceutical companies such as AstraZeneca and Johnson & Johnson. With a robust marketing structure, Amoy Diagnostics has a direct sales network covering top hospitals in China and has expanded its international presence through subsidiaries in Singapore, Hong Kong, and Canada, as well as a warehouse in the Netherlands.

The company’s major advantages are solid R&D base, distribution channel, brand image and innovative products. Since founded, the Company has attached great importance to R&D and technological innovation; setting up dual R&D centers in Xiamen and Shanghai, being clinical and patient centric, being down-to-earth and taking the initiatives to build strictly compliant PCR, NGS, FISH, IHC platforms for precision medicine, the Company's annual R&D investment accounts for more than 15% of the revenue. Over ten years’ steady growth in R&D investment and intensive R&D development, the globally leading and fully independent intellectual property rights of technologies, ADx-ARMS®, Super-ARMS®, ddCapture®, ADx-HANDLE®, as well as ADx-GSS® technologies, has laid a technical foundation for its sustainable development. Based on the advantages of these core technologies, the Company offers a wide portfolio of detection assays covering multiple cancer types, most of which are first-in-class and unique in China and NMPA approved, some are CE-marked in Europe, some are registered in Japan and South Korea and included on its National Health Insurance List. The company has established a strong compound R&D team with high technical level and rich industry experience. It has participated in a number of national, provincial and ministerial-level projects such as the 863 Program, the National Science and Technology Major Project, and the Health Industry Scientific Research Project. The Company has been qualified as National Center of Enterprise Technology, Postdoctoral Programme, and etc. On the basis of technology and product advantages, the Company has a sound marketing structure. Domestic market: direct sales network covering top hospitals, the sales team consists of more than 400 people, a complete pre-sales and after-sales team provides marketing, medical and technical supports activities; moreover, the Company actively expand cooperation with pharmaceutical companies. In the international market: the Company has more than 70 full-time employees are responsible for international business and business development. The Company has wholly-owned subsidiaries in Singapore, Hong Kong, and Canada, and one European warehouse in the Netherlands. It cooperates closely with oncologists, customers, and pharmaceutical companies to continuously promote local registrations and marketing. At the same time, the Company's products participate in the clinical trials of the original research drugs of many pharmaceutical companies in the form of companion diagnostics, and make every effort to develop the international market. The Company is a partner of multinational pharmaceutical companies including AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Pfizer, etc. It has won a good market reputation and extensive customer recognition, and has become an internationally renowned Chinese brand.